News

Quinnova Pharmaceuticals, a specialty pharmaceutical company, has received the FDA clearance for the company’s new product Neosalus Cream, a line extension to the previously launched Neosalus Foam, the

Germany-based biotechnology company Evotec has reported the results of a Phase II proof-of-concept study investigating the potential of EVT 302, a reversible and selective inhibitor of monoamine oxidase

GlobalChem 2009 was initiated by leaders at EPA and Capitol Hill, as well as industry and international experts to discuss on developments in chemical risk management policies in

Irving Weissman, director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine, said the SCNT technique is one way to create disease-specific human embryonic stem cell lines

Pfizer and Medivation, a biopharmaceutical company reported the initiation of a 12-month, Phase III clinical trial of the investigational drug Dimebon.  The study, known as Concert, is designed

Biogen Idec has received similar approval from the European Medicines Agency for the high titer process in December 2008. The new, higher-yield process will be used to manufacture

The newborn and preterm infant population has varying degrees of fragile, underdeveloped skin that can be easily damaged by adhesives. Coupled with Casmed’s unique Cool-Light technology which eliminates

The company has reported a revenue of $1.04 billion for the first quarter of 2009, a 10% increase, compared to $942.19 million for the first quarter of 2008.

The company has reported net sales of $2.82 billion for the first quarter of 2009, a decrease of 2%, compared to $2.87 billion for the first quarter of